Dose Finding Trial of Rosuvastatin and Atorvastatin Versus Hepatitis C

Different Doses of rosuvastatin and atorvastatin will be used to see if HCV viral load changes and liver tests change.

Completed

Looking for future studies?

Key information

Conditions

Hepatitis C Blood-Borne Infections Communicable Diseases Digestive System Diseases Flaviviridae Infections Hepatitis Hepatitis, Viral, Human Infections Liver Diseases RNA Virus Infections Virus Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

VA Hospital

Oklahoma City, Oklahoma, 73104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hepatitis C

Exclusion criteria

HIV positivity

Treatment and study plan

Rosuvastatin

Drug

atorvastatin

Drug

Sponsors and collaborators

Lead sponsor

Bader, Ted, M.D.

Indiv

Registry information

Important dates

Study start: 2006
Study completion: 2007
First posted: Mar 13, 2007
Registry last updated: Sep 9, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed